Aurinia Pharmaceuticals Inc.

NASDAQ:AUPH

Biotechnology

Healthcare
$15.13 +0.81%

+$0.13 today

Market cap
$2.03B
Beta
1.43
P/E (TTM)
7.2
EPS (TTM)
$2.25
52W Low $7.29High $16.88

Volume 0.76M

Average 1.21M

AUPH Other Current Assets

Current assets not reported separately, such as prepaid expenses.

Aurinia Pharmaceuticals Inc.NASDAQ: AUPH

Other Current Assets · Q2 FY2026 · quarter ended Jun 2026

Other current assets rises 107.7% from a year ago

Other current assets stood at $1.38M at the end of Q2 FY2026, up 107.7% from a year earlier and down 21.4% from the prior quarter. Over 3 fiscal years it compounded at -6.8% a year.

Context

  • Other current assets amounted to 0.2% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
  • Other current assets increased in 1 of the last 3 fiscal years.

What to watch

Whether other current assets keeps rising in the next quarterly balance sheet after a +107.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.38M-21.4% QoQ
Last fiscal yearDec 2025
$1.08M-4.3% YoY
Year agoJun 2025
$665K+107.7% since
Other Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+107.7%——
1 year-4.3%——
3-year CAGR-6.8%——
5-year CAGR——
10-year CAGR——

Other Current Assets history

USD · from the balance sheet

Latest · FY2025
1.08M USD
Year-over-year change
-4.3%
4-year CAGR
+7.9%

Other Current Assets vs competitors

How AUPH compares with its peers on the latest reported figures

  • AUPH's Jun 2026 other current assets of $1.38M is the 7th highest of the 10 companies compared; the peer median is $3.27M.
  • Its year-over-year change of +107.7% is the 2nd highest of 8, against a peer median of -66.1%.
  • Other current assets amounts to 0.2% of total assets for AUPH, versus a peer median of 1.4%.
AUPH Competitors Peer median
Other Current Assets for AUPH and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MLTXMoonLake ImmunotherapeuticsMar 2026$32.96M ——8.2%
BHVNBiohaven Ltd.Jun 2026$28.69M +243.3%-65.9%7.7%
ALMSAlumis Inc. Common StockJun 2026$7.93M -66.1%+233.6%1.4%
EVMNEvommune, Inc.Mar 2026$4.39M -25.7%—1.4%
ATTOAttovia Therapeutics, Inc.Jun 2026$3.27M ——2.5%
TRAXFirst Tracks Biotherapeutics IncMar 2026$2.95M +100.8%—1.0%
AUPHAurinia Pharmaceuticals Inc.Jun 2026$1.38M +107.7%-6.8%0.2%
ELDNEledon Pharmaceuticals, Inc.Mar 2026$9K -83.6%-26.8%0.0%
VERAVera Therapeutics, Inc.Jun 2026$0 -100.0%+52.2%0.0%
ACRSAclaris Therapeutics, Inc.Mar 2026$0 -100.0%+59.8%0.0%
Peer median (excluding AUPH) $3.27M-66.1%+52.2%1.4%

Competitors are the stored peer set for AUPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents231.9M94.17M48.88M83.43M80.21M
Short-term Investments234.18M295.22M301.61M275.04M317.78M
Net Receivables15.41M13.48M24.09M36.54M41.45M
Inventory19.33M24.75M39.71M39.23M45.69M
Other Current Assets796K1.33M1.03M1.13M1.08M
Total Current Assets513.32M442.54M424.8M446.6M491.97M
Property, Plant & Equipment (Net)9.8M8.56M116.57M98.87M79.57M
Goodwill00000
Intangible Assets8.4M6.43M4.98M4.36M3.76M
Long-term Investments00201K00
Tax Assets0000176.19M
Other Non-current Assets11.84M13.34M1.52M823K93K
Total Non-current Assets30.04M28.32M123.26M104.05M259.62M
Total Assets543.37M470.86M548.06M550.65M751.59M
Account Payables3.88M3.09M4.33M5.19M3.31M
Short-term Debt00000
Tax Payables814K625K667K00
Deferred Revenue190K3.15M4.81M11M3.72M
Other Current Liabilities4.45M2.03M1.59M1.53M2.48M
Total Current Liabilities40.65M46.11M77.19M97.76M93.72M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)000012.65M
Other Non-current Liabilities15.95M12.17M10.91M11.11M6.66M
Total Non-current Liabilities23.63M19.32M92.92M75.4M76.53M
Total Liabilities64.28M65.43M170.11M173.17M170.26M
Common Stock1.18B1.19B1.2B1.19B1.12B
Retained Earnings(756.12M)(864.3M)(942.32M)(936.57M)(649.37M)
Accumulated OCI(852K)(1.06M)(730K)(647K)(599K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity479.09M405.44M377.95M377.48M581.33M
Total Debt8.74M8.09M97.61M79.37M74.81M
Net Debt(223.16M)(86.08M)48.73M(4.06M)(5.4M)

Aurinia Pharmaceuticals Inc.

NASDAQ:AUPH

Intrinsic Alpha fair value

Locked

Current Price

$15.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.